Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

Completed · Phase 3

Conditions studied: Epilepsies, Partial

In brief

The study will evaluate the long-term safety and tolerability of pregabalin in pediatric patients, age 1 month through 16 years, with partial onset seizures.

Key facts

Study ID
NCT00448916
Run by
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
People needed
54
Starts
2007-05-01
Expected to finish
2013-10-01
Last updated by the study team
2021-01-25

Who can join

Age: 0 and older, up to 16. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.